OBJECTIVE: Little is known about the interaction between human papillomavirus (HPV) and HIV. This study aimed to explore the association of oncogenic (high risk) and nononcogenic (low risk) HPV with HIV incidence. METHODS: We used 1683 urethral swabs collected at the last follow-up visit of a male circumcision trial conducted in Orange Farm (South Africa). Swabs analyses and HPV genotyping were performed by polymerase chain reaction. We estimated HIV adjusted incidence rate ratios (aIRRs) and 95% confidence intervals (CIs) using survival analysis. Background characteristics, male circumcision status, sexual behavior, HPV status, and other sexually transmitted infections were used as covariates. RESULTS: The prevalence of HR and LR HPV was 14.0% (95% CI: 12.4 to 15.7) and 17.3% (95% CI: 15.6 to 19.2), respectively. When controlling for HR-HPV status, LR-HPV status was not associated with HIV incidence (aIRR = 1.13, 95% CI: 0.40 to 3.16; P = 0.82). When controlling for all covariates, HIV incidence increased significantly with HR-HPV positivity (aIRR = 3.76, 95% CI: 1.83 to 7.73, P < 0.001) and with the number of HR-HPV genotypes (adjusted-P linear trend = 0.0074). CONCLUSIONS: Several explanations could account for our findings. One is that HR-HPV facilitates HIV acquisition. The association of HPV with HIV acquisition requires further investigations.
OBJECTIVE: Little is known about the interaction between human papillomavirus (HPV) and HIV. This study aimed to explore the association of oncogenic (high risk) and nononcogenic (low risk) HPV with HIV incidence. METHODS: We used 1683 urethral swabs collected at the last follow-up visit of a male circumcision trial conducted in Orange Farm (South Africa). Swabs analyses and HPV genotyping were performed by polymerase chain reaction. We estimated HIV adjusted incidence rate ratios (aIRRs) and 95% confidence intervals (CIs) using survival analysis. Background characteristics, male circumcision status, sexual behavior, HPV status, and other sexually transmitted infections were used as covariates. RESULTS: The prevalence of HR and LR HPV was 14.0% (95% CI: 12.4 to 15.7) and 17.3% (95% CI: 15.6 to 19.2), respectively. When controlling for HR-HPV status, LR-HPV status was not associated with HIV incidence (aIRR = 1.13, 95% CI: 0.40 to 3.16; P = 0.82). When controlling for all covariates, HIV incidence increased significantly with HR-HPV positivity (aIRR = 3.76, 95% CI: 1.83 to 7.73, P < 0.001) and with the number of HR-HPV genotypes (adjusted-P linear trend = 0.0074). CONCLUSIONS: Several explanations could account for our findings. One is that HR-HPV facilitates HIV acquisition. The association of HPV with HIV acquisition requires further investigations.
Authors: P Mayaud; D K Gill; H A Weiss; E Uledi; L Kopwe; J Todd; G ka-Gina; H Grosskurth; R J Hayes; D C Mabey; C J Lacey Journal: Sex Transm Infect Date: 2001-08 Impact factor: 3.519
Authors: N Coleman; H D Birley; A M Renton; N F Hanna; B K Ryait; M Byrne; D Taylor-Robinson; M A Stanley Journal: Am J Clin Pathol Date: 1994-12 Impact factor: 2.493
Authors: Susie B Baldwin; Danelle R Wallace; Mary R Papenfuss; Martha Abrahamsen; Linda C Vaught; Anna R Giuliano Journal: Sex Transm Dis Date: 2004-10 Impact factor: 2.830
Authors: Bethany A Weaver; Qinghua Feng; King K Holmes; Nancy Kiviat; Shu-Kuang Lee; Christine Meyer; Mike Stern; Laura A Koutsky Journal: J Infect Dis Date: 2004-01-29 Impact factor: 5.226
Authors: Iain J Macleod; Belinda O'Donnell; Sikhulile Moyo; Shahin Lockman; Roger L Shapiro; Mukendi Kayembe; Erik van Widenfelt; Joseph Makhema; M Essex; Carolyn Wester Journal: J Med Virol Date: 2011-10 Impact factor: 2.327
Authors: Staci L Sudenga; B Nelson Torres; Matthys H Botha; Michele Zeier; Martha E Abrahamsen; Richard H Glashoff; Susan Engelbrecht; Maarten F Schim Van der Loeff; Louvina E Van der Laan; Siegfried Kipping; Douglas Taylor; Anna R Giuliano Journal: J Infect Date: 2015-10-19 Impact factor: 6.072
Authors: Sarah H Averbach; Patti E Gravitt; Rebecca G Nowak; David D Celentano; Megan S Dunbar; Charles S Morrison; Barbara Grimes; Nancy S Padian Journal: AIDS Date: 2010-04-24 Impact factor: 4.177
Authors: Mary K Grabowski; Xiangrong Kong; Ronald H Gray; David Serwadda; Godfrey Kigozi; Patti E Gravitt; Fred Nalugoda; Steven J Reynolds; Maria J Wawer; Andrew D Redd; Stephen Watya; Thomas C Quinn; Aaron A R Tobian Journal: J Infect Dis Date: 2015-11-23 Impact factor: 5.226
Authors: Aaron A R Tobian; Mary K Grabowski; Godfrey Kigozi; Andrew D Redd; Kevin P Eaton; David Serwadda; Toby C Cornish; Fred Nalugoda; Stephen Watya; Denis Buwembo; James Nkale; Maria J Wawer; Thomas C Quinn; Ronald H Gray Journal: J Infect Dis Date: 2013-01-23 Impact factor: 5.226
Authors: Frank Tanser; Kyle G Jones; Johannes Viljoen; John Imrie; Erofili Grapsa; Marie-Louise Newell Journal: Sex Transm Dis Date: 2013-07 Impact factor: 2.830